• Resize Text
    • Small Text
    • Medium Text
    • Large Text
    • Connect
Central Nervous System
Central Nervous System

Mirtazapine Oral Solution

Mirtazapine is an oral medicine used for the treatment of depression.

Mirtazapine is indicated for:

adults for the treatment of episodes of major depression.

Icon respresenting a network

Summary of Product Characteristics

Read this summary of product characteristics for further information about Mirtazapine Oral Solution. Click below to navigate to the EMC.

More info
Icon respresenting a person

Patient Information Leaflet

Read this patient information leaflet about Mirtazapine Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.

More info
Central Nervous System

Mirtazapine Oral Solution

Mirtazapine Oral Solution
Click here for Audio Version
Flavour Orange
Storage Conditions Do not store above 25°C
Sucrose Free
Shelf Life (Closed Bottle/Open Bottle) 36 months / 6 weeks
PIP Code 110-5758
EAN Code 50-16119-32469-7
Sodium Levels Essentially sodium-free
Ethanol Concentration 2.35mg/ml

Downloads

Adverse Drug Events

Information about adverse event reporting can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Rosemont Pharmaceuticals Ltd on 0113 244 1400

Rosemont Pharmaceuticals - World Map icon

Contact us

For further product information and pricing please use the form below and a member of the team will be in touch






    Please prove you are human by selecting the tree.

    Stay updated via our App

     

    A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.

    Rosemont app on a mobile device

    Central Nervous System

    Mirtazapine Oral Solution

    Mirtazapine Oral Solution